期刊文献+

高效液相色谱法测定血浆中西洛他唑浓度及药动学 被引量:1

The determination of cilostazol plasma levels and pharmacokinetics using HPLC
下载PDF
导出
摘要 目的:建立测定血浆中西洛他唑浓度的高效液相色谱法,考察西洛他唑在中国健康志愿者体内的药动学行为.方法:血浆样品经液-液提取后,进行色谱分离测定.结果:西洛他唑的最低定量浓度为25.0μg·L-1,线性范围为25.0~2000.0μg·L-1,精密度与准确度符合生物样品分析要求.结论:该法操作简便、快速、灵敏度高.可检测出健康志愿者口服100 mg西洛他唑72 h后的血浆浓度,适于临床药动学研究. OBJECTIVE A rapid and sensitive HPLC method for the analysis of cilostazol in plasma was developed and the pharmacokinetics of cilostazol in China healthy volunteers was studied. METHODS Plasma samples containing cilostazol and midazolam (internal standard, IS ) were extracted with liquid-liquid extraction, followed by liquid chromatographic separation and determination. RESULTS The limits of quantitation of method for cilostazol was 25.0 μg·L -1 , the calibration curves in plasma was linear in the range of 25.0 to 2 000.0 μg·L -1 and intra and inter-day precision over this range were less than 11.4% . CONCLUSION The method is shown to be accurate, robust and convenient, and suitable for clinical pharmacokinetics study.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2005年第4期345-347,共3页 Chinese Journal of Hospital Pharmacy
关键词 西洛他唑 高效液相色谱 药动学 cilostazol HPLC pharmacokinetics
  • 相关文献

参考文献4

  • 1Schror K. The pharmacology of cilstazol [J]. Diabetes Obes Metab. , 2002, 4(Supple2) :S14.
  • 2Akiymam H, Kudo S, Odomi M, et al. High-perfermance liquid chromatographic procedure for the determination of a new antithrombotic and vasodilating agent, cilostazol, in human plasma[J]. J Chromatogr B Biomed Sci Appl, 1985, 338:456.
  • 3Steven L, Bramer, William P. Relative bioavailability and effects of a high fat meal on single dose clistazol pharmacokinetics[J].Clin Pharmacokinet, 1999, 37(Suppl2): 13.
  • 4Woo SK, Kang WK, Kwon KI. Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans[J]. Clin Pharmacokinet, 2002, 71(4): 246.

同被引文献2119

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部